| Ytd | -83.17% | |
| 1y | -88.45% |
| Open | 3.14 | Prev Close | 3.08 | Low | 2.99 | High | 3.20 | Mkt Cap | 6.94M |
| Vol | 44.75K | Avg Vol | 3.50M | EPS | -3.72 | P/E | -0.83 | Forward P/E | -4.48 |
| Beta | 2.63 | Short Ratio | 0.46 | Inst. Own | 0.40% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.45 | 200-d Avg | 13.99 | 1yr Est | 3.37 |
Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's afte
Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signin
CAESAREA, Israel, Aug. 5, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceC
The petition by The Society of Interventional Oncology (SIO) includes adding criteria for patients a
Company signed agreement with the West Cancer Center & Research Institute, the first clinical site f
CAESAREA, Israel, July 14, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "Ice
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark
Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventiona
CAESAREA, Israel, June 25, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "Ice
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's reg
U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares j
Published in the International Journal of Surgery, globally ranked in the top three among surgery jo
U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Thera
CAESAREA, Israel, June 17, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "Ice
IceCure Medical Ltd. (NASDAQ:ICCM) shares are soaring Wednesday after the company reported a 70% jum
Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Signif
U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m
Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy
At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated
No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares CAESAREA, Israel,
IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript
IceCure Medical Ltd. (ICCM) came out with a quarterly loss of $0.06 per share versus the Zacks Conse
Pent-up demand immediately following FDA clearance generates 46% increase in active customer account
CAESAREA, Israel, May 6, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCu
As the only FDA cleared minimally invasive treatment option for low-risk breast cancer, ProSense® is
The Company's participation at the Society of Breast Imaging Symposium and other upcoming medical co
During Friday's session, 574 stocks hit new 52-week lows.
On Tuesday, 400 companies set new 52-week lows.